Do They, or Don't They? Integrase Strand Transfer Inhibitors, Tenofovir Alafenamide, and Excessive Weight Gain in People With HIV
The Journal of Infectious Diseases · 15.10.2026 · 234 (4) · 497-499
DOI: 10.1093/infdis/jiag365 ↗Kurz gefasst
Kommentar in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 16.07.2026. Verfasst von David Alain Wohl. Beteiligte Einrichtung: The Institute of Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Institute of Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill.
ORCID-Profile: David Alain Wohl
Zitieren
APA
Wohl, D. A. (2026). Do They, or Don't They? Integrase Strand Transfer Inhibitors, Tenofovir Alafenamide, and Excessive Weight Gain in People With HIV. The Journal of Infectious Diseases, 234(4), 497-499. https://doi.org/10.1093/infdis/jiag365
Vancouver
Wohl DA. Do They, or Don't They? Integrase Strand Transfer Inhibitors, Tenofovir Alafenamide, and Excessive Weight Gain in People With HIV. The Journal of Infectious Diseases. 2026;234(4):497-499. doi:10.1093/infdis/jiag365
BibTeX
@article{Wohl2026,
author = {Wohl, David Alain},
title = {Do They, or Don't They? Integrase Strand Transfer Inhibitors, Tenofovir Alafenamide, and Excessive Weight Gain in People With HIV},
journal = {The Journal of Infectious Diseases},
year = {2026},
volume = {234},
number = {4},
pages = {497--499},
doi = {10.1093/infdis/jiag365}
}
EUVIMED